Literature DB >> 12513061

Hematopoietic stem-cell transplantation for the Bernard-Soulier syndrome.

Franco Locatelli, Gabriele Rossi, Carlo Balduini.   

Abstract

Mesh：

Year:  2003        PMID： 12513061     DOI： 10.7326/0003-4819-138-1-200301070-00028

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations.

Authors:  Anna Savoia; Annalisa Pastore; Daniela De Rocco; Elisa Civaschi; Mariateresa Di Stazio; Roberta Bottega; Federica Melazzini; Valeria Bozzi; Alessandro Pecci; Silvana Magrin; Carlo L Balduini; Patrizia Noris
Journal:  Haematologica       Date:  2010-12-20       Impact factor: 9.941

2.  Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy.

Authors:  Sachiko Kanaji; Erin L Kuether; Scot A Fahs; Jocelyn A Schroeder; Jerry Ware; Robert R Montgomery; Qizhen Shi
Journal:  Mol Ther       Date:  2011-11-01       Impact factor: 11.454

Review 3.  Treatment of inherited thrombocytopenias.

Authors:  Carlo L Balduini
Journal:  Haematologica       Date:  2022-06-01       Impact factor: 11.047

Review 4.  Pathogenesis and management of inherited thrombocytopenias: rationale for the use of thrombopoietin-receptor agonists.

Authors:  Alessandro Pecci
Journal:  Int J Hematol       Date:  2013-05-01       Impact factor: 2.490

5.  Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.

Authors:  Pierre-Alexandre Laurent; Carlo Zaninetti; Christian A Di Buduo; Larissa Lordier; Paolo M Soprano; Aikaterini Ntai; Serena Barozzi; Alberto La Spada; Ida Biunno; Hana Raslova; James B Bussel; David L Kaplan; Carlo L Balduini; Alessandro Pecci; Alessandra Balduini
Journal:  Elife       Date:  2021-06-01       Impact factor: 8.140

Review 6.  Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy).

Authors:  François Lanza
Journal:  Orphanet J Rare Dis       Date:  2006-11-16       Impact factor: 4.123
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.